SNDL
SNDL Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.44
+1.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 21.31x
- P/S forward
- 0.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.46x
- Price / sales
- 0.53x
- Price / cash flow
- 7.66x
Enterprise value
- Enterprise value
- $341.7M
- EV / sales
- 0.51x
- EV / EBITDA
- 12.60x
- EV / EBIT
- -29.88x
- Market cap
- $356.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026